In 2004, a new substance was synthesized by the group of professor Vladimir P. Skulachev in the Moscow StateUniversity. Our project team later gave the substance its “production” name “SkQ1". Two commercial entities Mitotech Russia and Mitotech EU were established around 2010 with an aim to develop SkQ1 into a drug targeting several age-related indications.
Web Design
Foundation
